Skip to main content
Investor Relations Contact Us Careers
Nasdaq: FEMY

Cancer Diagnosis

Cancer Diagnosis “>”>Diagnostic product Femasys has achieved global regulatory approvals for a next generation diagnostic product for cervical cancer. Cancer Diagnosis Cervical cancer tissue sampling options have been the same for many decades.  Although HPV vaccination is available, endocervical curettage is recommended for certain patients according to the National Institutes of Health.1  Every year in […]